Found: 14
Select item for more details and to access through your institution.
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac206
- By:
- Publication type:
- Article
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38892-w
- By:
- Publication type:
- Article
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215984, doi. 10.1001/jamanetworkopen.2022.15984
- By:
- Publication type:
- Article
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. 1, doi. 10.1001/jamanetworkopen.2022.15984
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e239135, doi. 10.1001/jamanetworkopen.2023.9135
- By:
- Publication type:
- Article
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 3, p. 390, doi. 10.1093/cid/ciab990
- By:
- Publication type:
- Article
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 2, p. 271, doi. 10.1093/cid/ciac780
- By:
- Publication type:
- Article
Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants.
- Published in:
- Pediatric Allergy & Immunology, 2015, v. 26, n. 4, p. 316, doi. 10.1111/pai.12390
- By:
- Publication type:
- Article
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50376-z
- By:
- Publication type:
- Article
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 3, p. 1, doi. 10.1371/journal.pntd.0011124
- By:
- Publication type:
- Article
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 3, p. e647, doi. 10.1093/infdis/jiae081
- By:
- Publication type:
- Article
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e279, doi. 10.1093/infdis/jiae067
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 6, p. 761, doi. 10.1093/infdis/jiac327
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2077, doi. 10.1093/infdis/jiab505
- By:
- Publication type:
- Article